跳至主要内容
临床试验/NCT04177862
NCT04177862已完成4 期

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

University of Minnesota1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2019年12月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
75
试验地点
1
主要终点
Recovery Room Time

研究概览

简要总结

The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.

详细描述

This is a level I randomized prospective outcomes study comparing two groups of patients. Upon arrival in the ambulatory surgery center (ASC) post-anesthesia care unit (PACU) if the patient has a pain score of 4 or greater they will then be randomized to one of two groups. Group 1 will receive 50 mcg of IV fentanyl and group 2 will receive 30 mcg of sublingual sufentanil. The primary outcome assessed will be time of readiness to discharge after arrival in the post-anesthesia care unit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • undergoing outpatient ambulatory surgery
  • recipient of general anesthesia
  • pain score of 4 or greater in the PACU

排除标准

  • non-english speaking patients
  • cancer surgeries
  • patients who have allergy or intolerance to the study drugs or derivatives
  • patients on chronic opioids (defined as daily opioids for 3 months or longer)

研究组 & 干预措施

Sublingual Sufentanil

Experimental

Single dose of sublingual sufentanil for acute pain.

干预措施: Sublingual Sufentanil (Drug)

IV Fentanyl

Active Comparator

single dose of IV fentanyl for acute pain.

干预措施: IV Fentanyl (Drug)

结局指标

主要结局

Recovery Room Time

时间窗: 1 day

The time (reported in minutes) from when the patient arrives in the PACU, right after surgery, to the time that all discharge criteria are met.

次要结局

  • Rescue Milligram Morphine Equivalents (Opioid Use After Intervention Until Discharge)(1 day)
  • Adverse Events(1 day)
  • Postoperative Nausea and Vomiting (PONV)(1 day)
  • Supplemental Oxygen(1 day)
  • Overall Benefit of Analgesic Score (OBAS)(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验